JAFKX Mutual Fund

NAV$20.46

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
1.24%
Dividend Yield (Current)
15.85%
Holdings
171
Inception Date
Jan 28, 2002
Fund Family
John Hancock
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.20%
1 Year+31.91%

Asset Allocation

Stocks: 98.86%
Other: 1.14%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.36%
ISRGINTUITIVE SURG4.49%
TMOThermo Fisher4.28%
ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs3.94%
SYKStryker Corp 3.375 11/253.54%
Top 10 Concentration: 42.96%Report Date: Dec 31, 2025
Download all 171 holdings for JAFKX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
15.85%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how JAFKX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

JAFKX Mutual Fund Overview

JAFKX Mutual Fund (John Hancock Variable Insurance Trust Health Sciences Trust Series II) is managed by John Hancock. JAFKX expense ratio is 1.24%, holding 171 positions across sectors including Health Care, Unknown, Financials. Inception date: 2002-01-28.

JAFKX performance shows a YTD return of 7.20%. The 1-year return is 31.91%. JAFKX dividend yield stands at 15.85%, paid annually.

JAFKX top holdings include Eli Lilly & Co (12.4%), INTUITIVE SURG (4.5%), Thermo Fisher (4.3%), Argenx Se Spon Adr Each Rep 1 Ord Shs (3.9%), Stryker Corp 3.375 11/25 (3.5%). View all JAFKX holdings, sector breakdown, or dividend history.

JAFKX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JAFKX alternatives are available via the screener, along with tax-loss harvesting opportunities.